Global Next Generation Cancer Diagnostics Market Size Study, By Technology (NGS, LOAC & RT-PCR), By Application (CTC, Biomarker), By Cancer Type (Lung, Breast), By Function Companion Diagnostics) and Regional Forecasts, 2017-2025

For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global Next Generation Cancer Diagnostics Market is valued approximately USD 5.8 billion in 2016 and is expected to grow at 16.5% CAGR during the forecast period. Owing to the early diagnosis and more precised prognosis of various types of cancer, the next generation cancer diagnostics are gaining faster adoption. Moreover, increasing cases of oncology and advancements in genomics research are primarily driving the market growth.

Global Next Generation Cancer Diagnostics MarketThe objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the global infertility treatment market are given below:

Technology:

  • NGS-based cancer diagnostics
  • qPCR & Multiplexing
  • Lab-on-a-chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
  • Protein microarray-based cancer diagnostics
  • DNA microarray-based cancer diagnostics

Type:

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Others

Applications:

  • Biomarker Development
  • CTC Analysis
  • Proteomic Analysis
  • Epigenetic Analysis
  • Genetic Analysis

Functions:

  • Therapeutic Monitoring
  • Companion Diagnostics
  • Prognostic Diagnostics
  • Cancer Screening
  • Risk Analysis

Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year – 2015

Base year – 2016

Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are;  Novartis AG, F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Abbott , GE Healthcare , Thermo Fisher Scientific, Inc.

Target Audience of the Next Generation Cancer Diagnostics Market Study

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Chapter 1.           Research Methodology

1.1.         Research Process

1.1.1.     Data Mining

1.1.2.     Analysis

1.1.3.     Market Estimation

1.1.4.     Validation

1.1.5.     Publishing

1.2.         Research Assumption

Chapter 2.           Global Next Generation Cancer Diagnostics Market Definition & Scope

2.1.         Objective of The Study

2.2.         Market Definition

2.3.         Scope of The Study

2.4.         Years Considered for The Study

2.5.         Currency Conversion Rates

2.6.         Report Limitation

Chapter 3.           Executive Summary

3.1.         Key Trends

3.2.         Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)

Chapter 4.           Global Next Generation Cancer Diagnostics Industry Dynamics

4.1.         Growth Prospects

4.1.1.     Drivers

4.1.2.     Restraints

4.1.3.     Opportunities

4.2.         Industry Analysis

4.2.1.     Porter’s 5 Force Model

4.2.2.     PEST Analysis

4.2.3.     Value Chain Analysis

4.3.         Analyst Recommendation & Conclusion

Chapter 5.           Global Next Generation Cancer Diagnostics Market by Technology

5.1.         Market Snapshot

5.2.         Next Generation Cancer Diagnostics Market, Sub Segment Analysis

5.2.1.     NGS-based cancer diagnostics

5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.2.     qPCR & Multiplexing

5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.3.     Lab-on-a-chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)

5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.4.     Protein microarray-based cancer diagnostics

5.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.5.     DNA microarray-based cancer diagnostics

5.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

Chapter 6.           Global Next Generation Cancer Diagnostics Market by Type

6.1.         Market Snapshot

6.2.         Next Generation Cancer Diagnostics Market, Sub Segment Analysis

6.2.1.     Lung Cancer

6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.2.     Breast Cancer

6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.3.     Colorectal Cancer

6.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.4.     Cervical Cancer

6.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.5.     Others

6.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

Chapter 7.           Global Next Generation Cancer Diagnostics Market by Application

7.1.         Market Snapshot

7.2.         Next Generation Cancer Diagnostics Market, Sub Segment Analysis

7.2.1.     Biomarker Development

7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.2.     CTC Analysis

7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.3.     Proteomic Analysis

7.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.4.     Epigenetic Analysis

7.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.5.     Genetic Analysis

7.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

Chapter 8.           Global Next Generation Cancer Diagnostics Market by Function

8.1.         Market Snapshot

8.2.         Next Generation Cancer Diagnostics Market, Sub Segment Analysis

8.2.1.     Therapeutic Monitoring

8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

8.2.2.     Companion Diagnostics

8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

8.2.3.     Prognostic Diagnostics

8.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

8.2.4.     Cancer Screening

8.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

8.2.5.     Risk Analysis

8.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

8.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

Chapter 9.           Global Next Generation Cancer Diagnostics Market, Regional Analysis

9.1.         Next Generation Cancer Diagnostics Market, Regional Market Snapshot (2015-2025)

9.2.         North America Next Generation Cancer Diagnostics Market Snapshot

9.2.1.     U.S. Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)

9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

9.2.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.2.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.2.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.2.2.     Canada Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)

9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

9.2.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.2.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.2.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.         Europe Next Generation Cancer Diagnostics Market Snapshot

9.3.1.     U.K. Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)

9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.2.     Germany Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)

9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.3.     France Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)

9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.3.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.4.     Rest of Europe Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)

9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.4.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.3.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.         Asia Next Generation Cancer Diagnostics Market Snapshot

9.4.1.     China Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)

9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.2.     India Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)

9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.3.     Japan Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)

9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.3.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.4.     Rest of Asia Pacific Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)

9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.4.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.4.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.5.         Rest of The World Next Generation Cancer Diagnostics Market Snapshot

9.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

9.5.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.5.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

9.5.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)

Chapter 10.         Competitive Intelligence

10.1.      Company Market Share (Subject to Data Availability)

10.2.      Top Market Strategies

10.3.      Company Profiles

10.3.1.   Abbott

10.3.1.1.               Overview

10.3.1.2.               Financial (Subject to Data Availability)

10.3.1.3.               Product Summary

10.3.1.4.               Recent Developments

10.3.2.   Agilent Technologies (Dako)

10.3.3.   Almac Group

10.3.4.   Cepheid

10.3.5.   F. Hoffmann-La Roche Ltd

10.3.6.   GE Healthcare

10.3.7.   Illumina, Inc.

10.3.8.   Janssen Global Services, LLC

10.3.9.   Koninklijke Philips N.V.

10.3.10.                Novartis AG

10.3.11.                Perkin Elmer, Inc.

10.3.12.                Qiagen

10.3.13.                Thermo Fisher Scientific, Inc.

 

 

 

The research for Global Next Generation Cancer Diagnostics market focuses deeply on the entire value chain of the market. The market numbers are calculated by conducting a detailed study across each technology segment, which includes the current market scenario, upcoming technologies, major factors influencing the technology, technological developments and government regulations applied across various technologies. The total market numbers are calculated by following both Top-down and Bottom-up approaches while performing data triangulation on various secondary and primary data available. Some key data points considered to calculate the revenue for global next-generation cancer diagnostics market include:

  • Industry Structure
  • Rising need for effective cancer diagnostics
  • Rising incidences of oncology
  • Cost of diagnostic procedure
  • Government regulations impacting the MRI systems market
  • Technological advancements in the industry

Each of our research reports, go through an extensive process of primary and secondary research. Various government websites/portals and paid data sources are considered as the key source of secondary research. Our team of analysts conducts extensive primary research across key industry people, through questionnaires, telephonic conversations, email conversations, and interviews.

 


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,950

Enterprise License – $5,550

Loading…